Development and Validation of a Predictive Model Combining [18F] FDG PET/CT and the Suidan Score for Primary Optimal Cytoreduction in Advanced High-Grade Serous Ovarian Cancer: A Retrospective Cohort Study
Medical Science Monitor · 2026
DOI: 10.12659/msm.951183 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Medical Science Monitor, 2026. Verfasst von Xiaohang Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Positron Emission Tomography Computed Tomography, Cytoreduction Surgical Procedures, Cystadenocarcinoma, Serous. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gynaecology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
- Department of Nuclear Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Zitieren
APA
Lu, X., Wang, X., Wang, S., Huang, J., Wei, W., Kang, F., & Wang, N. (2026). Development and Validation of a Predictive Model Combining [18F] FDG PET/CT and the Suidan Score for Primary Optimal Cytoreduction in Advanced High-Grade Serous Ovarian Cancer: A Retrospective Cohort Study. Medical Science Monitor. https://doi.org/10.12659/msm.951183
Vancouver
Lu X, Wang X, Wang S, Huang J, Wei W, Kang F, et al. Development and Validation of a Predictive Model Combining [18F] FDG PET/CT and the Suidan Score for Primary Optimal Cytoreduction in Advanced High-Grade Serous Ovarian Cancer: A Retrospective Cohort Study. Medical Science Monitor. 2026. doi:10.12659/msm.951183
BibTeX
@article{Lu2026,
author = {Lu, Xiaohang and Wang, Xiaomei and Wang, Shengnan and Huang, Jiazhen and Wei, Wei and Kang, Fuli and Wang, Ning},
title = {Development and Validation of a Predictive Model Combining [18F] FDG PET/CT and the Suidan Score for Primary Optimal Cytoreduction in Advanced High-Grade Serous Ovarian Cancer: A Retrospective Cohort Study},
journal = {Medical Science Monitor},
year = {2026},
doi = {10.12659/msm.951183}
}
EUVIMED